[BGLC] QoQ Quarter Result on 30-Sep-2020 [#Q3]

Stock
[BGLC] BioNexus Gene Lab Corp.
Announcement Date
03-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- 449.25%
YoY- 1,163.64%
Quarter Report
BGLC's Result
BGLC's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 3,092 3,449 11,360 23 7 3,070 53 1407.94%
PBT 137 339 1,435 -60 -66 -47 -96 -
Tax 108 0 167 0 0 1 -4 -
NP 28 339 1,269 234 -67 1,070 -93 -
Tax Rate -79.30% 0.00% -11.61% - - - - -
Total Cost 3,064 3,110 10,092 -211 73 2,000 146 662.24%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin 0.91 9.82 11.17 998.93 -1,017.23 34.84 -174.51 -
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
EPS 0.00 0.02 -0.02 0.03 -0.01 0.12 -0.01 -
EPS Diluted 0.00 0.02 -0.02 0.03 -0.01 0.12 -0.01 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.